TrialHaematologica2015

Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.

Carol Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.